EditorialPublished 1 Dec 2025
Combating Bloodstream Infections: Diagnostics, Resistance, and Prevention
Dept. of Infectious Diseases, Florence Biomedical University, Italy
Abstract
Select any words in the title or abstract, or press this and choose a sentence.
Bloodstream infections (BSIs) pose a significant global health burden, necessitating advancements in diagnostics, antimicrobialstewardship, and early, targeted therapy. The persistent threat of antimicrobial resistance (AMR) drives the need for novel treatmentstrategies and optimized stewardship programs. Rapid molecular diagnostics are improving pathogen identification, while fungalBSIs and sepsis-associated delirium require specialized management. The emergence of multidrug-resistant organisms like CREcomplicates treatment, emphasizing the importance of new antimicrobial agents and infection control. Biomarkers assist in diagnosisand therapy guidance, and understanding BSIs in the context of vector-borne diseases is crucial. Vaccine development represents akey preventive measure against BSIs.
Keywords
Subjects
Infectious DiseasesAsk about this article
Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.
Follow
New articles from what you follow go into your email digest, once you agree to alert emails.
- JournalJournal of Clinical Infectious Diseases & Practice
- SubjectInfectious Diseases
- BylineArticles whose byline prints “Dr. Marco DeLuca”
